Xintela

Xintela EBIT Margin

The EBIT Margin (Operating Margin) of Xintela (XINT.ST) as of Oct 21, 2026 is -2,045.75 %. In the previous year, EBIT Margin (Operating Margin) was -935.87 % — a change of 118.59% (lower).

EBIT Margin

-2,045.75 %

YoY

118.59%

Last updated:

EBIT Margin (Operating Margin) of Xintela is 2025 -2,045.75 % . EBIT Margin (Operating Margin) of Xintela was 2024 -935.87 % . It decreases by 118.59% lower compared to the previous year.

For Xintela, the operating (EBIT) margin of -2,045.7% is down versus -1,486.7% a few years ago.

The Xintela EBIT Margin history

  • 3 Years

  • 10 Years

  • 25 Years

  • Max

EBIT Margin
Date
EBIT Margin
Jan 1, 2015
-1,521.00 SEK
Jan 1, 2016
-569,900.00 SEK
Jan 1, 2017
-1.10 M SEK
Jan 1, 2018
-1,486.73 SEK
Jan 1, 2019
-100,123.68 SEK
Jan 1, 2023
-73,380.77 SEK
Jan 1, 2024
-935.87 SEK
Jan 1, 2025
-2,045.75 SEK
The Xintela EBIT Margin history
YEAREBIT MarginYoY
-2,045.75 %+118.59%
-935.87 %-98.72%
-73,380.77 %-26.71%
-100,123.68 %+6,634.48%
-1,486.73 %-99.86%
-1.10 M %+92.43%
-569,900.00 %+37,368.67%
-1,521.00 %-94.90%
-29,852.11 %—

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

Xintela Stock analysis

What does Xintela do? Xintela AB, based in Lund, Skåne, develops pharmaceutical products in the Health Care sector, specifically focusing on regenerative medicine for cartilage damage and osteoarthritis, as well as treatments for glioblastoma brain tumors. The company utilizes therapeutic antibodies and XINMARK, a marker technology using specific proteins to identify stem cells for cartilage development. Listed on 22 March 2016, Xintela operates within biotechnology, targeting innovative therapies in oncology and orthopedics. Xintela is one of the most popular companies on Eulerpool.

Frequently Asked Questions about Xintela stock

EBIT Margin (Operating Margin) of Xintela is -2,045.75 % in 2025.

EBIT Margin (Operating Margin) of Xintela changed from -935.87 % to -2,045.75 %, representing a 118.59% change. The value is lower than the previous year.

On Eulerpool you can find the complete historical development of EBIT Margin (Operating Margin) Xintela since 2006 – with annual values, charts, and detailed analysis.

EBIT Margin measures operating profitability as a percentage of revenue. It shows how much profit a company makes from operations before interest and taxes.

A 'good' varies by industry and company stage. On Eulerpool, you can compare EBIT Margin (Operating Margin)'s Xintela with sector peers and the industry average to assess whether it is attractive.

To evaluate EBIT Margin (Operating Margin)'s, it is essential to compare it with peers in the same industry and sector. On Eulerpool, you can find direct industry comparisons for EBIT Margin (Operating Margin).

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

Margins — Xintela

All Key Metrics — Xintela